Semaxanib is a potent and selective synthetic inhibitor of the Flk-1/KDR vascular endothelial growth factor (VEGF) receptor tyrosine kinase.
Semaxanib is an effective and targeted synthetic agent that inhibits the Flk-1/KDR vascular endothelial growth factor (VEGF) receptor tyrosine kinase.